Boulos & Cooper Pharmaceuticals is an Australian proprietary company incorporated in October 2013 and is based in Perth, Western Australia. The company is focused on the development of a new class of antibiotics with novel targets. Being a pioneer in the field, the company wholly owns a strong and expanding IP portfolio with patents granted in AU and the US in addition to a number of other provisional and PCT filings. Boulos & Cooper Pharmaceuticals has successfully established a robust framework with a number of industry partners for the development of its key areas of research, operating leanly and maximising investment in research.
We are proud of our progress and achievements to date and we remain focussed on the work ahead. We believe that innovative and promising technologies are the key to creating true value for our investors.